Skip to main content
SpringerLink
Log in
Book cover

Case Studies in Multiple Sclerosis pp 91–96Cite as

Cognitive impairment

  • Chapter
  • First Online:

  • 1015 Accesses

Abstract

A 52-year-old man with a 24-year history of multiple sclerosis (MS) presented for his annual visit with his neurologist. His last relapse was 11 years prior and since that time he noted a slow worsening of his MS symptoms and has been formally diagnosed with secondary progressive (SPMS) for 7 years. He has never been on any disease-modifying therapy (DMT). He is otherwise healthy but does smoke a pack of cigarettes per day and drinks approximately eight beers per week. His main symptoms had been fatigue, which responds well to modafinil, and bladder urgency. However, his main complaint during this visit pertained to his memory.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Achiron A, Chapman J, Magalashvili D, et al. Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS One. 2013;8:e71058.

    Google Scholar 

  2. Amato MP, Zipoli V, Goretti B, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol. 2006;253:1054-1059.

    Google Scholar 

  3. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991;41:685-691.

    Google Scholar 

  4. Achiron A, Polliack M, Rao SM, et al. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry. 2005;76:744-749.

    Google Scholar 

  5. Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc.. 2006;12:549-558.

    Google Scholar 

  6. Cummings JL. Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry. 1986;149:682-697.

    Google Scholar 

  7. Turner MA, Moran NF, Kopelman MD. Subcortical dementia. Br J Psychiatry. 2002;180:148-151.

    Google Scholar 

  8. Aarsland D, Karlsen K. Neuropsychiatric aspects of Parkinson’s disease. Curr Psychiatry Rep. 1999;1:61-68.

    Google Scholar 

  9. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7:1139-1151.

    Google Scholar 

  10. Benedict RH, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol. 2002;16:381-397.

    Google Scholar 

  11. Duque B, Sepulcre J, Bejarano B, Samaranch L, Pastor P, Villoslada P. Memory decline evolves independently of disease activity in MS. Mult Scler. 2008;14:947-953.

    Google Scholar 

  12. Kujala P, Portin R, Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain. 1997;120 (Pt 2):289-297.

    Google Scholar 

  13. Amato MP, Portaccio E, Goretti B, et al. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler. 2010;16:1474-1482.

    Google Scholar 

  14. Morrow SA, Jurgensen S, Forrestal F, Munchauer FE, Benedict RH. Effects of acute relapses on neuropsychological status in multiple sclerosis patients. J Neurol. 2011;258:1603-1608.

    Google Scholar 

  15. Benedict RH, Morrow S, Rodgers J, et al. Characterizing cognitive function during relapse in multiple sclerosis. Mult Scler. 2014;20:1745-52.

    Google Scholar 

  16. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 1991;41:692-696.

    Google Scholar 

  17. Hakim EA, Bakheit AM, Bryant TN, Roberts MW, McIntosh-Michaelis SA, Spackman AJ, et al. The social impact of multiple sclerosis–a study of 305 patients and their relatives. Disabil Rehabil. 2000;22:288-293.

    Google Scholar 

  18. Ruet A, Deloire M, Hamel D, Ouallet JC, Petry K, Brochet B. Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study. J Neurol. 2013;260:776-784.

    Google Scholar 

  19. Morrow SA, Drake A, Zivadinov R, Munschauer F, Weinstock-Guttman B, Benedict RH. Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol. 2010;24:1131-1145.

    Google Scholar 

  20. Flensner G, Landtblom AM, Soderhamn O, Ek AC. Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study. BMC Public Health. 2013;13:224.

    Google Scholar 

  21. Katz IR, Sands LP, Bilker W, DiFilippo S, Boyce A, D’Angelo K. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc. 1998;46:8-13.

    Google Scholar 

  22. Low LF, Anstey KJ, Sachdev P. Use of medications with anticholinergic properties and cognitive function in a young-old community sample. Int J Geriatr Psychiatry. 2009;24:578-584.

    Google Scholar 

  23. Salinsky M, Storzbach D, Munoz S. Cognitive effects of pregabalin in healthy volunteers: a double-blind, placebo-controlled trial. Neurology. 2010;74:755-761.

    Google Scholar 

  24. Oken BS, Flegal K, Zajdel D, et al. Cognition and fatigue in multiple sclerosis: Potential effects of medications with central nervous system activity. J Rehabil Res Dev. 2006;43:83-90.

    Google Scholar 

  25. Lerdal A, Celius EG, Krupp L, Dahl AA. A prospective study of patterns of fatigue in multiple sclerosis. Eur J Neurol. 2007;14:1338-1343.

    Google Scholar 

  26. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil. 1984;65:135-138.

    Google Scholar 

  27. Morrow SA, Weinstock-Guttman B, Munschauer FE, Hojnacki D, Benedict RH. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis. Mult Scler. 2009;15:998-1005.

    Google Scholar 

  28. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler. 2007;13:67-72.

    Google Scholar 

  29. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol. 1990;47:98-104.

    Google Scholar 

  30. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry. 2005;76:469-475.

    Google Scholar 

  31. Akbar N, Honarmand K, Feinstein A. Self-assessment of cognition in Multiple Sclerosis: the role of personality and anxiety. Cogn Behav Neurol. 2011;24:115-121.

    Google Scholar 

  32. Demaree HA, Gaudino E, DeLuca J. The relationship between depressive symptoms and cognitive dysfunction in multiple sclerosis. Cogn Neuropsychiatry. 2003;8:161-171.

    Google Scholar 

  33. Benedict RH, Munschauer F, Linn R, et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 2003;9:95-101.

    Google Scholar 

  34. Freedman MS, Selchen D, Arnold DL, et al. Treatment optimization in MS: Canadian MS Working Group updated recommendations. Can J Neurol Sci. 2013;40:307-323.

    Google Scholar 

  35. Langdon DW, Amato MP, Boringa J, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012;18:891-898.

    Google Scholar 

  36. Lapshin H, Lanctot KL, O’Connor P, Feinstein A. Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis. Mult Scler. 2013;19:1905-1912.

    Google Scholar 

  37. Van Schependom J, D’Hooghe M B, Cleynhens K, et al. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis. Eur J Neurol. 2014;21:1219-1225.

    Google Scholar 

  38. Morrow S, O’Connor P, Polman C, et al. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Mult Scler. 2010;16:1385-1392.

    Google Scholar 

  39. Benedict RH, Cox D, Thompson LL, Foley F, Weinstock-Guttman B, Munschauer F. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler. 2004;10:675-678.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. London Health Sciences Multiple Sclerosis Clinic, University of Western Ontario, London, Ontario, Canada

    Sarah Morrow

  2. University of Western Ontario, London, Ontario, Canada

    Sarah Morrow

Authors
  1. Sarah Morrow
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. McGill University , MONTREAL, Québec, Canada

    Paul S. Giacomini

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Morrow, S. (2017). Cognitive impairment. In: Giacomini, P. (eds) Case Studies in Multiple Sclerosis. Adis, Cham. https://doi.org/10.1007/978-3-319-31190-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31190-6_12

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-31188-3

  • Online ISBN: 978-3-319-31190-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation